Veracyte (VCYT) Tops Q2 EPS by 2c

Go back to Veracyte (VCYT) Tops Q2 EPS by 2c

Veracyte Announces Second Quarter 2020 Financial Results

July 30, 2020 4:05 PM EDT

Revenue of $20.7 Million and Genomic Testing Volume of 5,379

Company Advances Pipeline and Global Expansion Strategy

Conference Call and Webcast Today at 4:30 p.m. ET

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the second quarter ended... More